|
⚲
|
| Keyboard |
| Eversept Partners LP
✚
|
|
|---|---|
| CRD # | 282358 |
| SEC # | 801-108771 |
| CIK # | 0001697013 |
| AUM | 2,651.0 M (2026-03-31) |
| Employees | 10 (50% Investors, 0% Brokers) |
| Phone | 212-271-4200 |
| Address | 444 Madison Avenue New York, NY 10022 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($B) |
|---|
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| United Therapeutics Corp | 0.2 | ||
| Abivax Sa | 0.1 | ||
| GlaxoSmithKline PLC | 0.1 | ||
| Vera Therapeutics Inc | 0.1 | ||
| Natera Inc | 0.1 | ||
| Syndax Pharmaceuticals Inc | 0.1 | ||
| Celldex Therapeutics Inc | 0.1 | ||
| Vaxcyte Inc | 0.1 | ||
| Brookdale Senior Living Inc | 0.0 | ||
| ISIS Pharmaceuticals Inc | 0.0 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Eversept Generations Fund LP | [2021-03-24] | 322.6 M | 470.5 M |
| Filed 2025-10-15 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Eversept ELS Master Fund LP | [2018-03-29] | 41.8 M | 97.9 M |
| Filed 2025-10-15 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Eversept Global Healthcare Fund LP | [2016-03-31] | 110.2 M | 1,745.7 M |
| Filed 2025-10-15 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Commission $499,813 · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 1 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 8 | 2.6 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 9 | 2.7 |
| By Discretionary | ||
| Discretionary | 9 | 2.7 |
| Non-Discretionary | 0 | 0.0 |
| Total | 9 | 2.7 |
| By Non-United States Persons | ||
| Non-United States Persons | 1.1 | |
| United States Persons | 1.6 | |
| Total | 9 | 2.7 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Scott Lennon | Director | 163 | 37 | |
| Richard Ruffer | Director | 422 | 15 | |
| Deanna Derrick | Director | 40 | 15 | |
| Kamran Moghtaderi | Director, Executive Officer | 5 | 3 | |
| Eversept Partners LP | Promoter | 4 | 3 | |
| Eversept Partners LLC | Promoter | 2 | 2 | |
| Eversept GP II LLC | Promoter | 1 | 1 | |
| Eversept GP III LP | Executive Officer | 1 | 1 | |
| Eversept GP III LLC | Promoter | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001697013] | |
| SC 13G | [0001697013] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Eversept Partners LP | Zimvie Inc | [2024-11-14] |
| Eversept Partners LP | Cabaletta Bio Inc | [2022-08-22] |
| Eversept Partners LP | Community Health Systems Inc | [2022-08-15] |
| Eversept Partners LP | Teligent Inc | [2019-09-06] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 549300X2D2KLB2XLNK52 |
| Comparable Firms | State | AUM |
|---|---|---|
|
Mangrove Partners IM LLC
✚
|
CT | 2,705.9 M |
|
1Sharpe Capital LLC
✚
|
CA | 2,700.3 M |
|
Hook Mill Capital Partners LP
✚
|
NY | 2,698.0 M |
|
Advanced Portfolio Management LLC
✚
|
NY | 2,697.1 M |
|
Gobi Capital LLC
✚
|
CA | 2,689.4 M |
|
Cadian Capital Management LP
✚
|
NY | 2,680.0 M |
|
Variant Investments LLC
✚
|
OR | 2,638.5 M |
|
Quinn Opportunity Partners LLC
✚
|
VA | 2,614.0 M |
|
Divisadero Street Capital Management LP
✚
|
FL | 2,611.3 M |
|
LCG Associates Inc
✚
|
GA | 2,608.7 M |